Now Playing

Pfizer Announces It's Splitting Up Its Drug Business

The world's largest drugmaker says it's planning on dividing its business into separate units for brand-name drugs and generics. The company's generics have a far lower profit margin than drugs protected by patents.

Trouble listening? See our technical support page.